Who is sponsoring NCT03847337?

NCT03847337 is sponsored by Vanderbilt University Medical Center.

What drugs are being tested in NCT03847337?

Interventions in NCT03847337: Telehealth-Screening Tool for Autism in Toddlers (STAT), Telehealth-Autism Spectrum Disorder-Pediatrics (ASD-PEDS).

What condition does NCT03847337 study?

NCT03847337 studies Autism Spectrum Disorder, Developmental Delay.

Is NCT03847337 still recruiting?

NCT03847337 is currently completed. Last updated 29 November 2022.

Are results published for NCT03847337?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2022-11-29 · How we verify

NCT03847337

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Can Novel Telemedicine Tools Reduce Disparities Related to Early Identification of Autism

Completed NA Results posted Last updated 29 November 2022

What this trial tests

NA trial testing Telehealth-Screening Tool for Autism in Toddlers (STAT) in Autism Spectrum Disorder in 144 participants. Completed in 30 September 2021.

Timeline

4 March 2019

Primary endpoint
30 September 2021

30 September 2021

Quick facts

Lead sponsor	Vanderbilt University Medical Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	diagnostic
Enrollment	144
Start date	4 March 2019
Primary completion	30 September 2021
Estimated completion	30 September 2021
Sites	1 location across United States

Drugs / interventions tested

Telehealth-Screening Tool for Autism in Toddlers (STAT)
Telehealth-Autism Spectrum Disorder-Pediatrics (ASD-PEDS)

Conditions studied

Autism Spectrum Disorder — all drugs for Autism Spectrum Disorder →
Developmental Delay — all drugs for Developmental Delay →

Sponsor

Vanderbilt University Medical Center

Who can join

Adults 15 Months to 3, any sex, with Autism Spectrum Disorder or Developmental Delay. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Accurate Diagnosis of Autism Via Telemedicine Primary · 1 day

Number of children who are accurately diagnosed with autism via diagnostic evaluation

Group	Value	95% CI
ASD-PEDS	61
TELE-STAT	63

Accurate Diagnosis of Developmental Delay Via Telemedicine Primary · 1 day

Number of children who are accurately diagnosed via diagnostic evaluation

Group	Value	95% CI
ASD-PEDS	7
TELE-STAT	2

Sponsor's own description

In this study, the investigators are trying to find new ways to screen for autism spectrum disorder (ASD) in young children. The investigators want to see if people like pediatricians can screen children for ASD while a psychologist watches on a monitor. The investigators are testing two screening tools. The investigators want to see if they are good at identifying children with ASD and children without ASD. The investigators hope this research will make it easier for families to get answers when there are concerns for ASD.

Publications & conference data

7 peer-reviewed publications reference this trial (live from Europe PMC):

Use of the TELE-ASD-PEDS for Autism Evaluations in Response to COVID-19: Preliminary Outcomes and Clinician Acceptability.
Wagner L, Corona LL, Weitlauf AS, Marsh KL, et al · · 2021 · cited 96× · PMID 33125622 · DOI 10.1007/s10803-020-04767-y
Parent Perceptions of Caregiver-Mediated Telemedicine Tools for Assessing Autism Risk in Toddlers.
Corona LL, Weitlauf AS, Hine J, Berman A, et al · · 2021 · cited 57× · PMID 32488583 · DOI 10.1007/s10803-020-04554-9
Transitioning to Telemedicine During COVID-19: Impact on Perceptions and Use of Telemedicine Procedures for the Diagnosis of Autism in Toddlers.
Wagner L, Weitlauf AS, Hine J, Corona LL, et al · · 2022 · cited 33× · PMID 34085153 · DOI 10.1007/s10803-021-05112-7
A Randomized Trial of the Accuracy of Novel Telehealth Instruments for the Assessment of Autism in Toddlers.
Corona LL, Wagner L, Hooper M, Weitlauf A, et al · · 2024 · cited 23× · PMID 37185923 · DOI 10.1007/s10803-023-05908-9
Expectations and Concerns about the Use of Telemedicine for Autism Spectrum Disorder: A Cross-Sectional Survey of Parents and Healthcare Professionals.
Gabellone A, Marzulli L, Matera E, Petruzzelli MG, et al · · 2022 · cited 22× · PMID 35743364 · DOI 10.3390/jcm11123294
Telemedicine and the assessment of clinician time: a scoping review.
Kidholm K, Jensen LK, Johansson M, Montori VM. · · 2023 · cited 16× · PMID 38099431 · DOI 10.1017/s0266462323002830
Provider and Caregiver Satisfaction with Telehealth Evaluation of Autism Spectrum Disorder in Young Children During the COVID-19 Pandemic.
Reisinger DL, Hines E, Raches C, Tang Q, et al · · 2022 · cited 10× · PMID 35579789 · DOI 10.1007/s10803-022-05576-1

Verify or expand the search:

Other recruiting trials for Autism Spectrum Disorder

Currently open trials in the same condition.

NCT07324057 — The Effects of Preoperative Intranasal Administration of Dexmedetomidine and Esketamine on Negative Postoperative Behavi · NA · recruiting
NCT07493096 — Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disor · recruiting
NCT07505290 — Efficacy of the Korean PEERS® for Preschoolers (PEERS®-PS-K) Social Skills Intervention: A Randomized Controlled Trial f · NA · active not recruiting
NCT07524192 — A Self-Instructional Online Program for Early Childhood and Elementary Teachers Supporting Autistic Children and Childre · NA · recruiting
NCT07432776 — Effect of an 8-Week Pickleball Program for Adults With Autism: A Feasibility Trial With a Delayed-Control Design · EARLY_PHASE1 · recruiting

Other Vanderbilt University Medical Center trials

Trials by the same sponsor.

NCT07005037 — Swallowing Impairments in ICU Survivors and Community-Dwelling Adults · not yet recruiting
NCT07527273 — Cognitive Enhancement in Recurrent Depression (The COG-D-R Study) · NA · not yet recruiting
NCT07295288 — Botox Injections in Non-Cranial Nerve VII Innervated Muscles for Facial Synkinesis · Phase 4 · not yet recruiting
NCT07431541 — Topical Carboxytherapy Paste Following Microneedling · Phase 1, PHASE2 · not yet recruiting
NCT07224711 — The Impact of Perioperative Lidocaine Infusions on Enhanced Recovery After Non-Cardiac Surgery · Phase 4 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03847337 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Vanderbilt University Medical Center
Last refreshed: 29 November 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03847337.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing